Effects of the US Food and Drug Administration Boxed Warning of Erythropoietin-Stimulating Agents on Utilization and Adverse Outcome.

Effects of the US Food and Drug Administration Boxed Warning of Erythropoietin-Stimulating Agents on Utilization and Adverse Outcome. J Clin Oncol. 2017 Jun 10; 35(17):1945-1951.

View in: PubMed

subject areas

Aged
Aged, 80 and over
Drug Labeling
Drug Utilization
Erythropoietin
Female
Hematinics
Humans
Male
Medicare
Middle Aged
Neoplasms
SEER Program
United States
United States Food and Drug Administration

authors with profiles

John Bian
Charles Lee Bennett
LeAnn Norris